Introduction
Gastric cancer is currently the fourth most common malignancy worldwide, with approximately 1 million new cases estimated in 2008 (989,000 cases, 7.8% of total cancers). 1, 2 In Korea, 29,727 individuals were diagnosed with cancer in 2008, and gastric cancer was the second most commonly occurring cancer, affecting 20.1% of men and 10.5% of women. 3 In countries without an appropriate screening system, gastric cancer is usually detected at a late stage. 4 The 5-year survival rates are much lower for patients with advanced gastric cancer than for those with early-stage gastric cancer, for whom survival rates can exceed 90%. 5 Use of endoscopy to screen for gastric cancer may facilitate early detection and improve survival, particularly in countries such as Korea and Japan that have a high incidence of gastric cancer. [5] [6] [7] However, the effect of screening with endoscopy on early diagnosis and treatment modality has rarely been reported. The proportion of patients with gastric at the Seoul National University Hospital (SNUH) who were diagnosed through the screening program was only 4.7% in 1996 and 17.2% in 2001. 9 The national screening rate has increased since that time, 10 and with an associated increase in the detection of early stage gastric cancers, there have been improvements in minimally invasive treatments such as endoscopic submucosal dissection (ESD) and laparoscopic gastrectomy.
This study aimed to evaluate the effect of screening by using endoscopy on the distribution of gastric cancer stages and treatment modalities at 5-year intervals since our last investigation in 2001.
Materials and Methods
We These proportions are considerably higher than those reported in our previous study (4.7% in 1996 and 17.2% in 2001). (Table 1) . Notably, the ratio of men to women in the screening group decreased from 3. (Fig. 2 ).
Patient-reported symptoms
In the symptomatic patients, non-specific epigastric pain was the most commonly reported symptom (Fig. 4) . Patients with gastrointestinal-related problems experienced diarrhea or constipation. Other patients had non-specific symptoms that included poor oral intake, fatigue, fever, chills, general weakness, swallowing difficulties, and hematuria.
Diagnosis occurred an average of 5.6±9.0 months after symptoms were reported, and this period was significantly longer in Values are presented as ratio of men to women, mean±standard deviation, or mean (numbers of men/women). *The screening group is distributed according to age. The most common symptoms in patients diagnosed with stage II to IV gastric cancer were obstruction, weight loss, and gastrointestinal bleeding.
Comparison of treatment modality between 2006 and 2011
The proportion of patients who underwent ESD significantly increased between 2006 (9.8%) and 2011 (19.1%; P＜0.001) ( Table   2 ). Following ESD, the proportion of ESD procedures that were 
Discussion
In this study, we documented the effect of gastric cancer screening by using endoscopy on the detection of gastric cancer and development of treatment modalities. The symptoms of gastric cancer are often non-specific (e.g., abdominal discomfort), which does not necessarily prompt an endoscopy. Therefore, the screening group in the present study consisted of patients for whom gastric cancer was detected through screening by using endoscopy 
